BioCina completes takeover of Pfizer-owned Australia plant; Cambrex adds space at NC site for small molecules

San Diego CDMO BioCina has finalized the final transition of its takeover of an Australian manufacturing site to boost its mRNA

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

BioCi­na com­pletes takeover of Pfiz­er-owned Aus­tralia plant; Cam­brex adds space at NC site for small mol­e­cules